Intercorp Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 27 Year, 6 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 M
as on 16-11-2024
- Revenue 36.24%
(FY 2023)
- Profit 141.06%
(FY 2023)
- Ebitda 118.42%
(FY 2023)
- Net Worth 21.23%
(FY 2023)
- Total Assets 31.48%
(FY 2023)
About Intercorp Biotech
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Padmashri Shrivastav, Anil Gupta, and Ajai Mishra serve as directors at the Company.
- CIN/LLPIN
U51101DL1997PLC091168
- Company No.
091168
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Dec 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Intercorp Biotech Limited offer?
Intercorp Biotech Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Hand Wash, Nutraceuticals & Dietary Supplements, Protein Powder, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Fertilizers and Soil Additives, Organic Fertilizers and Manure, Ind Chem, Food Grade Sanitizer.
Who are the key members and board of directors at Intercorp Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padmashri Shrivastav  | Director | 12-Apr-2024 | Current |
| Anil Gupta | Director | 29-Jan-2007 | Current |
| Ajai Mishra | Director | 26-Apr-2023 | Current |
Financial Performance and Corporate Structure Insights of Intercorp Biotech.
Intercorp Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.24% increase. The company also saw a substantial improvement in profitability, with a 141.06% increase in profit. The company's net worth Soared by an impressive increase of 21.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intercorp Biotech?
In 2023, Intercorp Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 Jan 2008 | ₹1.00 M | Satisfied |
How Many Employees Work at Intercorp Biotech?
Intercorp Biotech has a workforce of 38 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intercorp Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intercorp Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
